Study on the correlation between the number and function of endothelial progenitor cells and in-stent restenosis after stent-implantation for symptomatic intracranial atherosclerotic stenosis
Su Jiangli, Qi Lifeng, Zhang Rui, Qu Huaiqian
Department of Neurology, Liaocheng People′s Hospital, Shandong 252000, China
Abstract：Objective To explore the relationship of endothelium progenitor cells(EPCs) number and function, the level of vascular endothelial growth factor (VEGF) with in-stent restenosis after stent implantation for symptomatic intracranial atherosclerotic stenosis.Methods From Jan 2008 to October 2012, a total of 87 patients stent-implantation with symptomatic intracranial atherosclerotic stenosis (sICAS) were prospectively studied in Liaocheng People′s Hospital. In 87 patients, there were 48 males and 39 females, the age was 48-81 years. All the patients were divided into restenosis group and non-restenosis group according to the examining Results of Cranial CTA 1 year after percutaneous stent implantation. The EPCs number, adhesion and migration activities and the level of VEGF in the peripheral blood were tested and aralyzed in two groups.Results The 87 patients with symptomatic intracranial atherosclerotic stenosis were successfully performed percutaneous intravascular stent implantation, 23 patients showed varying degrees of in-stent restenosis 1 year after post-operatively, the restenosis rate of 14 patients was more than 50%. The number of endothelial progenitor cells [(36.5 ±4.8) /mL vs (65.6 ± 6.7) /mL], adhesion activities[(27.4 ± 7.3) /mL vs (58.5 ± 9.4) /mL], migration activities[(13.6±3.7) /mL vs (24.7±6.8) /mL] and level of VEGF[(57.79±13.53) pg/ mL vs (94.36±17.57) pg /mL]were significantly lower in restenosis group than non-restenosis group (t=19.110, 14.376, 7.425, and 9.051, respectively, all P values＜0.05).Conlusions The risk of in-stent restenosis is increased in the patients which the migration ability of EPC, and the level of EPC and VEGF will decrease significantly 1 year after postoperatively. It is helpful to judge the possibility of in-stent restenosis and certain clinical values for long-term prognosis of patients to detect the level of EPCs and VEGF. It may offer a new way for prevention of in-stent restenosis after stenting by changing the levels of EPCs and VEGF.
苏江利, 亓立峰, 张锐, 曲怀谦. 症状性颅内动脉狭窄支架置入术后内皮祖细胞的数量及功能与再狭窄的相关性研究[J]. 中华解剖与临床杂志, 2015, 20(2): 118-122.
Su Jiangli, Qi Lifeng, Zhang Rui, Qu Huaiqian. Study on the correlation between the number and function of endothelial progenitor cells and in-stent restenosis after stent-implantation for symptomatic intracranial atherosclerotic stenosis. Chinese Journal of Anatomy and Clinics, 2015, 20(2): 118-122.
Nam HS, Han SW, Lee JY, et al. Association of aortic plaque with intracranial atherosclerosis in patients with stroke[J]. Neurology, 2006, 67(7): 1184-1188.
[2]
De Silva DA, Woon FP, Lee MP, et al. South Asian patients with ischemic stroke: intracranial large arteries are the predominant site of disease[J]. Stroke, 2007, 38(9): 2592-2594.
[3]
Derdeyn CP, Chimowitz MI, Lynn MJ, et al. Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis ( SAMMPRIS) : the final results of a randomised trial[J]. Lancet, 2014, 383(9914) : 333-341.
[4]
Kernan WN, Ovbiagele B, Black HR, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare Professionals from the American Heart Association/American Stroke Association[J]. Stroke, 2014, 45(7): 2160-236.
Lee JH, Jo SM, Jo KD, et al. Comparison of drug-eluting coronary stents, bare coronary stents and self-expanding stents in angioplasty of middle cerebral artery stenoses[J]. J Cerebrovasc Endovasc Neurosurg[J]. 2013 ; 15(2): 85-95.
[7]
Jiang WJ, Yu W, Du B, et al. Outcome of patients with≥70% symptomatic intracranial stenosis after Wingspan stenting[J]. Stroke, 2011, 42(7): 1971-1975.
Yang H, Xu JX, Kong XZ, et al, Relations between plasma von Willebrand factor or endothelin-1 and restenosis following carotid artery stenting[J]. Med Princ Pract, 2012, 21(6): 538-542.
[10]
Xia ZY, Yang H, Qu HQ, et al, Expression of P-selectin, von Willebrand and endothelin-1 after carotid artery stenting[J]. Vasa, 2011, 40(3): 199-204.
Wojakowski W, Pyrlik A, Król M, et al. Circulating endothelial progenitor cells are inversely correlated with in-stent restenosis in patients with non-ST-segment elevation acute coronary syndromes treated with EPC-capture stents (JACK-EPC trial) [J]. Minerva Cardioangiol, 2013, 61(3): 301-311.
[13]
Wu CC, Huang PH, Lai CL, et al, The impact of endothelial progenitor cells on restenosis after percutaneous angioplasty of hemodialysis vascular access[J]. PLoS One, 2014, 9(6): e101058.
[14]
Dong C, Goldschmidt-Clermont PJ. Endothelial progenitor cells: a promising therapeutic alternative for cardiovascular disease[J]. J Interv Cardiol, 2007, 20( 2) : 93-99.
[15]
Ma X, Hibbert B, McNulty M, et al. Heat shock protein 27 attenuates neointima formation and accelerates reendothelialization after arterial injury and stent implantation: importance of vascular endothelial growth factor up-regulation[J]. FASEB J, 2014, 28(2): 594-602.
[16]
Nguyen-Huynh MN, Wintermark M, English J, et al. How accurate is CT angiography in evaluating intracranial atherosclerotic disease？[J]. Stroke, 2008, 39(4): 1184-1188.
2015, Vol. 20 
